Basal and therapy-driven hypoxia-inducible factor-1 alpha confers resistance to endocrine therapy in estrogen receptor-positive breast cancer | |
Jia, Xiaoqing; Hong, Qi; Lei, Li; Li, Daqiang; Li, Jianwei; Mo, Miao; Wang, Yujie; Shao, Zhimin; Shen, Zhenzhou; Cheng, Jingyi | |
刊名 | ONCOTARGET
![]() |
2015 | |
卷号 | 6期号:11 |
关键词 | HIF-1 alpha endocrine resistance zoledronic acid estrogen receptor breast cancer |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3436410 |
专题 | 昆明医科大学 |
推荐引用方式 GB/T 7714 | Jia, Xiaoqing,Hong, Qi,Lei, Li,et al. Basal and therapy-driven hypoxia-inducible factor-1 alpha confers resistance to endocrine therapy in estrogen receptor-positive breast cancer[J]. ONCOTARGET,2015,6(11). |
APA | Jia, Xiaoqing.,Hong, Qi.,Lei, Li.,Li, Daqiang.,Li, Jianwei.,...&Liu, Guangyu.(2015).Basal and therapy-driven hypoxia-inducible factor-1 alpha confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.ONCOTARGET,6(11). |
MLA | Jia, Xiaoqing,et al."Basal and therapy-driven hypoxia-inducible factor-1 alpha confers resistance to endocrine therapy in estrogen receptor-positive breast cancer".ONCOTARGET 6.11(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论